Instituto de Investigaciones del Sueno
About Instituto de Investigaciones del Sueno
"Centro multidisciplinar para el tratamiento y la investigación de los trastornos de sueño"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Idorsia Pharmaceuticals Ltd.
2
Eisai Inc.
1
H. Lundbeck A/S
1
Jazz Pharmaceuticals
1
Midnight Pharma, LLC
1
Pfizer
1
Clinical Trials at Instituto de Investigaciones del Sueno
During the past decade, Instituto de Investigaciones del Sueno conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia
2008-03-01
2009-11-01
Completed
709
Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
2016-05-31
2018-01-30
Completed
1,006
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
2017-03-14
2019-07-10
Completed
201
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
2018-06-04
2020-02-25
Completed
930
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
2018-10-09
2021-02-22
Completed
804
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
2021-04-28
2024-12-31
Recruiting
600
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
2021-06-30
2024-01-28
Recruiting
285
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto de Investigaciones del Sueno" #1 sponsor was "Idorsia Pharmaceuticals Ltd." with 2 trials, followed by "Eisai Inc." with 1 trials
sponsored, "H. Lundbeck A/S" with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "Midnight Pharma, LLC"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Instituto de Investigaciones del Sueno
According to Clinical.Site data, the most researched conditions in "Instituto de Investigaciones del Sueno" are
"Insomnia Disorder" (2 trials), "Acute Treatment of Migraine" (1 trials), "Chronic Migraine in Children" (1 trials), "Insomnia" (1 trials) and "Narcolepsy With Cataplexy" (1 trials). Many other conditions were trialed in "Instituto de Investigaciones del Sueno" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Investigaciones del Sueno
Most popular intervention types in "Instituto de Investigaciones del Sueno" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials), "Daridorexant 10 mg" (1 trials) and "Eptinezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Investigaciones del Sueno
The vast majority of trials in "Instituto de Investigaciones del Sueno" are
7 trials for "All" genders.
Clinical Trials Status at Instituto de Investigaciones del Sueno
Currently, there are NaN active trials in "Instituto de Investigaciones del Sueno".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Instituto de Investigaciones del Sueno,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Investigaciones del Sueno, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".